Cochrane · systematic review · CD012830

Pharmacologic interventions for mydriasis in cataract surgery

Iftikhar, M, Abariga, SA, Hawkins, BS, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

Eyes and VisionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
25
current version
GRADE rated
18
No studies
7
Included studies
NR
No studies 7 · 28%Ungraded 0 · 0%Very low 8 · 32%Low 9 · 36%Moderate 1 · 4%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Topical mydriatics compared to intracameral mydriatics for mydriasis in cataract surgery

Population: patients undergoing cataract surgery
11 questions
OutcomeEffectEvidenceStatus / GRADE
Mean pupillary diameter—at the time the surgeon performs capsulorhexis (mm)
Topical mydriatics vs intracameral mydriatics
no estimate extracted4 studies · 757 participantsLow
Downgraded: risk of bias, imprecision
Mean pupillary diameter—at the beginning of cataract surgery (mm)
Topical mydriatics vs intracameral mydriatics
no estimate extracted4 studies · 242 participantsLow
Downgraded: risk of bias, inconsistency
Mean pupillary diameter—at the end of cataract surgery (mm)
Topical mydriatics vs intracameral mydriatics
no estimate extracted5 studies · 799 participantsLow
Downgraded: risk of bias, inconsistency
Total intraoperative surgical time (min)
Topical mydriatics vs intracameral mydriatics
no estimate extracted5 studies · 817 participantsLow
Downgraded: risk of bias, imprecision
Total time it took for the surgeon to perform phacoemulsification (seconds)
Topical mydriatics vs intracameral mydriatics
no estimate extracted2 studies · 48 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
AE: participant‐reported ocular discomfort—week 1
Topical mydriatics vs intracameral mydriatics
RR 10.57 [1.37, 81.34]1 study · 555 participantsVery low
Downgraded: risk of bias, imprecision
AE: participant‐reported ocular discomfort—month 1
Topical mydriatics vs intracameral mydriatics
RR 2.51 [1.36, 4.65]1 study · 543 participantsModerate
Downgraded: risk of bias
AE: posterior capsule rupture
Topical mydriatics vs intracameral mydriatics
RR 0.32 [0.01, 7.83]1 study · 555 participantsLow
Downgraded: risk of bias, imprecision
AE: posterior capsule rupture—any time point during or after surgery
Topical mydriatics vs intracameral mydriatics
RR 0.32 [0.01, 7.83]1 study · 555 participantsLow
Downgraded: risk of bias, imprecision
AE: cystoid macular edema
Topical mydriatics vs intracameral mydriatics
RR 0.32 [0.01, 7.83]1 study · 555 participantsLow
Downgraded: risk of bias, imprecision
AE: cystoid macular edema ‐ any time point during or after surgery
Topical mydriatics vs intracameral mydriatics
RR 0.32 [0.01, 7.83]1 study · 555 participantsLow
Downgraded: risk of bias, imprecision

Topical mydriatics compared to depot delivery systems for mydriasis in cataract surgery

Population: patients undergoing cataract surgery
7 questions
OutcomeEffectEvidenceStatus / GRADE
Mean pupillary diameter—at the time the surgeon performs capsulorhexis (mm)
Topical mydriatics vs depot delivery systems
no estimate extractedNRNo studies
Mean pupillary diameter—at the beginning of cataract surgery (mm)
Topical mydriatics vs depot delivery systems
no estimate extracted5 studies · 324 participantsLow
Downgraded: risk of bias, inconsistency
Mean pupillary diameter—at the end of cataract surgery (mm)
Topical mydriatics vs depot delivery systems
no estimate extracted3 studies · 210 participantsVery low
Downgraded: risk of bias, inconsistency
Intraoperative surgical time—total intraoperative time (min)
Topical mydriatics vs depot delivery systems
no estimate extracted1 study · 58 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
AE: participant‐reported ocular discomfort—week 1
Topical mydriatics vs depot delivery systems
no estimate extractedNRNo studies
AE: participant‐reported ocular discomfort—month 1
Topical mydriatics vs depot delivery systems
no estimate extractedNRNo studies
AE: vitreous loss—any time point during or after surgery
Topical mydriatics vs depot delivery systems
no estimate extractedNRNo studies

Intracameral mydriatics compared to depot delivery systems for mydriasis in cataract surgery

Population: patients undergoing cataract surgery
7 questions
OutcomeEffectEvidenceStatus / GRADE
Mean pupillary diameter—at the time the surgeon performs capsulorhexis (mm)
Intracameral mydriatics vs depot delivery systems
no estimate extractedNRNo studies
Mean pupillary diameter—at the beginning of cataract surgery (mm)
Intracameral mydriatics vs depot delivery systems
no estimate extracted1 study · 60 participantsVery low
Downgraded: risk of bias, imprecision
Mean pupillary diameter—at the end of cataract surgery (mm)
Intracameral mydriatics vs depot delivery systems
no estimate extracted1 study · 60 participantsVery low
Downgraded: risk of bias, imprecision
Intraoperative surgical time—total intraoperative time (min)
Intracameral mydriatics vs depot delivery systems
no estimate extracted1 study · 60 participantsVery low
Downgraded: risk of bias, imprecision
AE: participant‐reported ocular discomfort—week 1
Intracameral mydriatics vs depot delivery systems
no estimate extractedNRNo studies
AE: participant‐reported ocular discomfort—month 1
Intracameral mydriatics vs depot delivery systems
no estimate extractedNRNo studies
Adverse events
Intracameral mydriatics vs depot delivery systems
no estimate extracted1 study · 60 participantsVery low
Downgraded: risk of bias, imprecision